Liquid biopsy to tailor the treatment of advanced hormone receptor-positive breast cancer in the era of novel endocrine agents and CDK4/6-inhibitors

在新型内分泌药物和 CDK4/6 抑制剂时代，液体活检可用于定制晚期激素受体阳性乳腺癌的治疗方案。